A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD

Clinical trial NCT03857841 · TERMINATED

Trial details

NCT number: NCT03857841
Sponsor: United Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Bronchopulmonary Dysplasia

Start date: 2019-10-09
Primary completion: 2021-05-20
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.